27
Nov, 2021
The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under 3 months of age with severe sepsis
27
Nov, 2021
The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under 3 months of age with severe sepsis
25
Nov, 2021
Inputs collected during the public consultation will be considered in the revision and finalization of the publication and infographics
15
Nov, 2021
Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants The University of Padua and Penta Foundation are leaders of VERDI, a new European research consortium on coronavirus in children and pregnant women. Carlo Giaquinto, Professor at University of Padova and President of Penta, together with Professor Ali Judd at University College London, will be the scientific coordinators of VERDI. Padova, Italy – 15 November 2021 Children and pregnant women have taken a back seat during the COVID-19 pandemic. With children most likely to be the last to be […]
12
Nov, 2021
It’s impossible to ignore the Covid-19 pandemic and how it has gripped the lives of everyone around the world, but it is equally impossible to ignore the thousands of lives that are lost daily to chest infections (pneumonia). According to UNICEF, pneumonia is the single largest cause of death in children under five and the majority of these deaths occur in low- and middle-income countries. Pneumonia needn’t be the deadly infectious disease that it is today. Through immunization, nutritional interventions, and controlling environmental risk factors the burden of child pneumonia can be […]
29
Oct, 2021
It was announced at the 8th European AIDS Conference that Angela Colbers and David Burger received the Hector Research Award in HIV 2021 in clinical and/or epidemiological science on behalf of the ODYSSEY trial team! The winning paper Simplified dolutegravir dosing for children with HIV weighting 20kg or more pharmacokinetic and safety substudies of the multicentre randomised ODYSSEY trial, can be found here. Congratulations to the entire study team and thank you to all the families and children who participated in the ODYSSEY trial. Sponsored by Penta and funded by […]
28
Sep, 2021
Authors: Anna Turkova on behalf of the ODYSSEY trial team Presented at: CHIVA 2021 Abstract ODYSSEY Internationalmulti-centre,randomised96-weeknon- inferiority trial WeaimedtocompareefficacyandsafetyofDTG-basedART with standard-of-care in children and adolescents starting first-line ART (ODYSSEY A) or second-line (ODYSSEY B) Main trial enrolled children≥14kg Aim to enrol ≥700 children: 310 ODYSSEY A, 390 ODYSSEY B Powered for efficacy (total population and A&B separately) Once enrolment in the main trial was completed, the trial was opened for ‘under 14kg cohort’ ‘Under 14kg’ cohort Aim to enrol ≥20 children in each of the three lower WHO […]
20
Sep, 2021
The Spanish language version of our online course “PentaTr@ining: HIV and other Congenital Infections” kicks off today! We look forward to welcoming over 100 participants for this year’s edition of our newly upgraded online training course. Unique in its design and delivery, ‘PentaTr@ining’ is an innovative training platform which continues to develop and evolve in response to the changing needs of children, young people and pregnant women living with HIV and other congenital infections. Our flagship online course is highly interactive and clinical case based, designed to kindle engagement and […]
15
Sep, 2021
To capture the early effects of the SARS-CoV-2 pandemic on pediatric clinical research.
7
Sep, 2021
Project New Generation (PNG+) are a group of young people living with HIV who serve as the voice of the youth involved in the REACH study. Made up of two groups, one based in St. Petersburg and the other in Irkutsk, and supported by local psychologists, this group of 20 bring to the forefront, issues that the youth living with HIV are directly affected by. The activities of PNG+ are led by the Penta PPI team. Pre-COVID-19, the PPI team held a number of in-person meetings with the young people, […]
